AB

Abalone Bio

YC W20

San Francisco, US · Founded 2018 · 14 employees · 1 known investors

abalonebio.com ↗

Abalone Bio develops target-activating antibodies for difficult-to-drug disease targets by combining engineered biology with machine learning. The company uses large-scale biological measurement platforms and AI-powered sequence analysis to discover functional antibody drugs for pharmaceutical and biotechnology applications.

Founders & leadership· Y Combinator alumni (W20)

Richard YuinCo-founder

Gustavo PesceinCo-founder

R

Richard

Investors · 1

Y

Y CombinatorMountain View · $500K – $500K